+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
BLISSGVS

Bliss GVS Pharma Share Price

₹632.00 +12.45 (2.01%)
435.59% Gain from 52W Low

05 Nov, 2026 2:17 PM (IST)

Bliss GVS Pharma live price: ₹632.00. It opened at ₹630 vs previous close ₹620; intraday high/low: ₹651/₹630. The 50 & 200 DMA stand at ₹631.10/₹460.70.

Bliss GVS Pharma Performance

  • Today's Low
  • ₹630
  • Today's High
  • ₹651
  • 52 Week Low
  • ₹118
  • 52 Week High
  • ₹740
  • Open Price₹630
  • Previous Close₹620
  • Volume73,968
  • 50 DMA₹631.10
  • 100 DMA₹568.10
  • 200 DMA₹460.70

Bliss GVS Pharma Chart

Investment Returns

  • Over 1 Month -7.55%
  • Over 3 Month + 29.05%
  • Over 6 Month + 130.57%
  • Over 1 Year + 311%

Smart Investing Starts Here Start SIP with Bliss GVS Pharma for Steady Growth!

Invest Now

Bliss GVS Pharma Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 41.7
  • PEG Ratio
  • 0.9
  • Market Cap Cr
  • 6,724
  • P/B Ratio
  • 5.4
  • Average True Range
  • 32
  • EPS
  • 15.2
  • Dividend Yield
  • 0.2
  • MACD Signal
  • -7.4
  • RSI
  • 44.06
  • MFI
  • 42.03

Latest Stock News Updates

Bliss GVS Pharma Ltd - 506197 - Intimation Under Regulations 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Grant Of Marketing Authorisation From MHRA, UK For Mesalazine 1G Suppositories

We wish to inform you that Asterisk Lifesciences Ltd, UK, a wholly owned subsidiary of Bliss GVS Pharma Limited, has obtained marketing authorization from the Medicines & Healthcare products Regulatory Agency (MHRA) for Mesalazine 1g Suppositiories.

Bliss GVS Pharma Ltd - 506197 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Please find enclosed herewith the Newspaper Publication regarding Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.

Bliss GVS Pharma Ltd - 506197 - Grant Of Options Under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019

Please find enclosed herewith the outcome of Nomination and Remuneration Committee meeting held today i.e. on October 29, 2026, the members has granted 2,95,000 stock options under Bliss GVS Pharma Limited - Employee Stock Option Plan 2019

Bliss GVS Pharma Financials

Bliss GVS Pharma Technicals

EMA & SMA

Current Price
₹632.00
+ 12.45 (2.01%)
pointer
  • Bearish Moving Average 9
  • Bullish Moving Average 7
  • 20 Day
  • ₹644.80
  • 50 Day
  • ₹631.10
  • 100 Day
  • ₹568.10
  • 200 Day
  • ₹460.70

Resistance and Support

637.57 Pivot Speed
  • R3 673.40
  • R2 655.20
  • R1 637.40
  • S1 601.40
  • S2 583.20
  • S3 565.40

Bliss GVS Pharma Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-10-29 Quarterly Results
2026-10-01 Employees Stock Option Plan
2026-08-12 Quarterly Results
2026-05-12 Audited Results & Final Dividend
2026-02-10 Quarterly Results & Interim Dividend
Date Purpose Remarks
2026-07-08 FINAL Rs.1.00 per share(100%)Final Dividend
2026-02-18 INTERIM Rs.0.50 per share(50%)Interim Dividend
2025-07-24 FINAL Rs.0.50 per share(50%)Final Dividend
View Bliss GVS Pharma Dividend History Arrow
Date Purpose Remarks
2008-03-18 Split Stock Split from Rs. 10/- to Re. 1/-.

Bliss GVS Pharma Shareholding Pattern

50.07%
35.29%
9.62%
5.03%

About Bliss GVS Pharma

Bliss GVS Pharma is engaged in manufacturing, marketing, trading and export of pharmaceutical products. The Company is one of among the world leaders in Suppositories and Pessaries dosage forms with one of the largest portfolios in this segment. View More
  • NSE Symbol
  • BLISSGVS
  • BSE Symbol
  • 506197
  • ISIN
  • INE416D01022

Similar Stocks to Bliss GVS Pharma

Bliss GVS Pharma FAQs

Bliss GVS Pharma share price is ₹632 As on 05 November, 2026 | 14:04

The Market Cap of Bliss GVS Pharma is ₹6723.5 Cr As on 05 November, 2026 | 14:04

The P/E ratio of Bliss GVS Pharma is 41.7 As on 05 November, 2026 | 14:04

The PB ratio of Bliss GVS Pharma is 5.4 As on 05 November, 2026 | 14:04

The 52 week High & Low of Bliss GVS Pharma is ₹739.9/₹118 respectively As on 05 November, 2026 | 14:04

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23